{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T01:59:53Z","timestamp":1775181593680,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13014-018-1202-z","type":"journal-article","created":{"date-parts":[[2018,12,24]],"date-time":"2018-12-24T03:02:35Z","timestamp":1545620555000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Progression of hearing loss after LINAC-based stereotactic radiotherapy for vestibular schwannoma is associated with cochlear dose, not with pre-treatment hearing level"],"prefix":"10.1186","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2205-3237","authenticated-orcid":false,"given":"A.","family":"van Linge","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"van Os","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Hoekstra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Heijmen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Stienstra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Dallenga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Wolbers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Mendez Romero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,12,24]]},"reference":[{"issue":"3","key":"1202_CR1","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s10143-011-0307-8","volume":"34","author":"BJ Arthurs","year":"2011","unstructured":"Arthurs BJ, Fairbanks RK, Demakas JJ, Lamoreaux WT, Giddings NA, Mackay AR, et al. A review of treatment modalities for vestibular schwannoma. Neurosurg Rev. 2011;34(3):265\u201377.","journal-title":"Neurosurg Rev"},{"issue":"5","key":"1202_CR2","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1097\/MOO.0b013e328357d337","volume":"20","author":"JJ Mulder","year":"2012","unstructured":"Mulder JJ, Kaanders JH, van Overbeeke JJ, Cremers CW. Radiation therapy for vestibular schwannomas. Curr Opin Otolaryngol Head Neck Surg. 2012;20(5):367\u201371.","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"1202_CR3","first-page":"13","volume":"3","author":"S Movsas","year":"2014","unstructured":"Movsas S. An audiological analysis of stereotactic radiation strategies to preserve hearing in patients with vestibular schwannomas. J Radiosurg. 2014;3:13\u201320.","journal-title":"J Radiosurg"},{"issue":"4","key":"1202_CR4","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.ijrobp.2010.10.010","volume":"79","author":"ES Murphy","year":"2011","unstructured":"Murphy ES, Suh JH. Radiotherapy for vestibular schwannomas: a critical review. Int J Radiat Oncol Biol Phys. 2011;79(4):985\u201397.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"1202_CR5","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.ijrobp.2011.04.066","volume":"81","author":"C Collen","year":"2011","unstructured":"Collen C, Ampe B, Gevaert T, Moens M, Linthout N, De Ridder M, et al. Single fraction versus fractionated linac-based stereotactic radiotherapy for vestibular schwannoma: a single-institution experience. Int J Radiat Oncol Biol Phys. 2011;81(4):503\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"1202_CR6","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ijrobp.2009.01.064","volume":"76","author":"SE Combs","year":"2010","unstructured":"Combs SE, Welzel T, Schulz-Ertner D, Huber PE, Debus J. Differences in clinical results after LINAC-based single-dose radiosurgery versus fractionated stereotactic radiotherapy for patients with vestibular schwannomas. Int J Radiat Oncol Biol Phys. 2010;76(1):193\u2013200.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"1202_CR7","doi-asserted-by":"publisher","first-page":"579","DOI":"10.3171\/2012.9.JNS12919","volume":"118","author":"ML Carlson","year":"2013","unstructured":"Carlson ML, Jacob JT, Pollock BE, Neff BA, Tombers NM, Driscoll CL, et al. Long-term hearing outcomes following stereotactic radiosurgery for vestibular schwannoma: patterns of hearing loss and variables influencing audiometric decline. J Neurosurg. 2013;118(3):579\u201387.","journal-title":"J Neurosurg"},{"issue":"5","key":"1202_CR8","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.ijrobp.2012.01.078","volume":"83","author":"R Rasmussen","year":"2012","unstructured":"Rasmussen R, Claesson M, Stangerup SE, Roed H, Christensen IJ, Caye-Thomasen P, et al. Fractionated stereotactic radiotherapy of vestibular schwannomas accelerates hearing loss. Int J Radiat Oncol Biol Phys. 2012;83(5):607\u201311.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"1202_CR9","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.radonc.2011.06.035","volume":"101","author":"DE Roos","year":"2011","unstructured":"Roos DE, Potter AE, Zacest AC. Hearing preservation after low dose linac radiosurgery for acoustic neuroma depends on initial hearing and time. Radiother Oncol. 2011;101(3):420\u20134.","journal-title":"Radiother Oncol"},{"issue":"4","key":"1202_CR10","doi-asserted-by":"publisher","first-page":"863","DOI":"10.3171\/2008.12.JNS08611","volume":"111","author":"H Kano","year":"2009","unstructured":"Kano H, Kondziolka D, Khan A, Flickinger JC, Lunsford LD. Predictors of hearing preservation after stereotactic radiosurgery for acoustic neuroma. J Neurosurg. 2009;111(4):863\u201373.","journal-title":"J Neurosurg"},{"issue":"6","key":"1202_CR11","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.3171\/2011.7.JNS11749","volume":"115","author":"T Hasegawa","year":"2011","unstructured":"Hasegawa T, Kida Y, Kato T, Iizuka H, Yamamoto T. Factors associated with hearing preservation after gamma knife surgery for vestibular schwannomas in patients who retain serviceable hearing. J Neurosurg. 2011;115(6):1078\u201386.","journal-title":"J Neurosurg"},{"issue":"3","key":"1202_CR12","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1227\/NEU.0b013e31821a42f3","volume":"69","author":"M Brown","year":"2011","unstructured":"Brown M, Ruckenstein M, Bigelow D, Judy K, Wilson V, Alonso-Basanta M, et al. Predictors of hearing loss after gamma knife radiosurgery for vestibular schwannomas: age, cochlear dose, and tumor coverage. Neurosurgery. 2011;69(3):605\u201313.","journal-title":"Neurosurgery"},{"issue":"3","key":"1202_CR13","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1002\/cncr.21190","volume":"104","author":"SH Paek","year":"2005","unstructured":"Paek SH, Chung HT, Jeong SS, Park CK, Kim CY, Kim JE, et al. Hearing preservation after gamma knife stereotactic radiosurgery of vestibular schwannoma. Cancer. 2005;104(3):580\u201390.","journal-title":"Cancer"},{"issue":"5","key":"1202_CR14","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1227\/NEU.0000000000000299","volume":"74","author":"JT Jacob","year":"2014","unstructured":"Jacob JT, Carlson ML, Schiefer TK, Pollock BE, Driscoll CL, Link MJ. Significance of cochlear dose in the radiosurgical treatment of vestibular schwannoma: controversies and unanswered questions. Neurosurgery. 2014;74(5):466\u201374.","journal-title":"Neurosurgery"},{"issue":"2","key":"1202_CR15","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.radonc.2012.10.013","volume":"106","author":"F Litre","year":"2013","unstructured":"Litre F, Rousseaux P, Jovenin N, Bazin A, Peruzzi P, Wdowczyk D, et al. Fractionated stereotactic radiotherapy for acoustic neuromas: a prospective monocenter study of about 158 cases. Radiother Oncol. 2013;106(2):169\u201374.","journal-title":"Radiother Oncol"},{"issue":"5","key":"1202_CR16","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/S0360-3016(01)01559-0","volume":"50","author":"DW Andrews","year":"2001","unstructured":"Andrews DW, Suarez O, Goldman HW, Downes MB, Bednarz G, Corn BW, et al. Stereotactic radiosurgery and fractionated stereotactic radiotherapy for the treatment of acoustic schwannomas: comparative observations of 125 patients treated at one institution. Int J Radiat Oncol Biol Phys. 2001;50(5):1265\u201378.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"1202_CR17","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/j.ijrobp.2010.04.057","volume":"80","author":"C Kopp","year":"2011","unstructured":"Kopp C, Fauser C, Muller A, Astner ST, Jacob V, Lumenta C, et al. Stereotactic fractionated radiotherapy and LINAC radiosurgery in the treatment of vestibular schwannoma-report about both stereotactic methods from a single institution. Int J Radiat Oncol Biol Phys. 2011;80(5):1485\u201391.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"1202_CR18","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1016\/S0360-3016(03)00444-9","volume":"56","author":"OW Meijer","year":"2003","unstructured":"Meijer OW, Vandertop WP, Baayen JC, Slotman BJ. Single-fraction vs. fractionated linac-based stereotactic radiosurgery for vestibular schwannoma: a single-institution study. Int J Radiat Oncol Biol Phys. 2003;56(5):1390\u20136.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1202_CR19","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1177\/000348948809700110","volume":"97","author":"G Gardner","year":"1988","unstructured":"Gardner G, Robertson JH. Hearing preservation in unilateral acoustic neuroma surgery. Ann Otol Rhinol Laryngol. 1988;97:55\u201366.","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"1202_CR20","doi-asserted-by":"crossref","unstructured":"Joiner M, van der Kogel A. Basic Clinical Radiobiology 2009.","DOI":"10.1201\/b15450"},{"issue":"5","key":"1202_CR21","doi-asserted-by":"publisher","first-page":"877","DOI":"10.3171\/2012.7.JNS10672","volume":"117","author":"SCR Yomo","year":"2012","unstructured":"Yomo SCR, Thomassin JM, Roche PH, R\u00e9gis J. Longitudinal analysis of hearing before and after radiosurgery for vestibular schwannoma. J Neurosurg. 2012;117(5):877\u201385.","journal-title":"J Neurosurg"},{"issue":"1","key":"1202_CR22","doi-asserted-by":"publisher","first-page":"29","DOI":"10.4103\/0973-1482.131353","volume":"10","author":"SD Sharma","year":"2014","unstructured":"Sharma SD, Chadha P, Talapatra K, Mahtre V, Kumar AP, Balasubramaniam A. Critical neurological structure sparing radiosurgery of vestibular schwannoma: dosimetric comparison of different techniques and dose prescription methods. J Cancer Res Ther. 2014;10(1):29\u201337.","journal-title":"J Cancer Res Ther"},{"key":"1202_CR23","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1097\/MAO.0000000000001672","volume":"39","author":"AR Coughlin","year":"2018","unstructured":"Coughlin AR, Tyler JW, Gubbels SP. Systematic review of hearing preservation Afeter radiotherapy for vestibular schwannoma. Otol Neurotol. 2018;39:273\u201383.","journal-title":"Otol Neurotol"},{"issue":"5","key":"1202_CR24","doi-asserted-by":"publisher","first-page":"917","DOI":"10.3171\/JNS-07\/11\/0917","volume":"107","author":"C Thomas","year":"2007","unstructured":"Thomas C, Di Maio S, Ma R, Vollans E, Chu C, Clark B, et al. Hearing preservation following fractionated stereotactic radiotherapy for vestibular schwannomas: prognostic implications of cochlear dose. J Neurosurg. 2007;107(5):917\u201326.","journal-title":"J Neurosurg"},{"issue":"3","key":"1202_CR25","doi-asserted-by":"publisher","first-page":"S50","DOI":"10.1016\/j.ijrobp.2009.04.096","volume":"76","author":"N Bhandare","year":"2010","unstructured":"Bhandare N, Jackson A, Eisbruch A, Pan CC, Flickinger JC, Antonelli P, Mendenhall WM. Radiation therapy and hearing loss. Int J Radiat Oncol Biol Phys. 2010;76(3):S50\u20137.","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-018-1202-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13014-018-1202-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-018-1202-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,23]],"date-time":"2019-12-23T19:05:45Z","timestamp":1577127945000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-018-1202-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1202"],"URL":"https:\/\/doi.org\/10.1186\/s13014-018-1202-z","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"27 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was exempted from the requirement for ethics approval by the Erasmus MC Rotterdam Medical Ethics Review Board (reference number MEC-2013-032). This work did not require any written patient consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"253"}}